𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

✍ Scribed by Ann-Lii Cheng; Zhongzhen Guan; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk Kim; Tsai-Sheng Yang; Won Young Tak; Hongming Pan; Shiying Yu; Jianming Xu; Fang Fang; Jessie Zou; Giuseppe Lentini; Dimitris Voliotis; Yoon-Koo Kang

Book ID
116430967
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
553 KB
Volume
48
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of sorafenib in pati
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
✍ Ann-Lii Cheng; Yoon-Koo Kang; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 195 KB

## Background: Most cases of hepatocellular carcinoma occur in the asia-pacific region, where chronic hepatitis b infection is an important aetiological factor. assessing the efficacy and safety of new therapeutic options in an asia-pacific population is thus important. we did a multinational phase